Cargando…

Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease

Given the lack of a serological test specific for Behçet's disease, its diagnosis rests upon clinical criteria. The clinical diagnosis is nevertheless difficult because the disease manifestations vary widely, especially at the onset of disease. The aim of this study was to identify molecules sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Delunardo, Federica, Conti, Fabrizio, Margutti, Paola, Alessandri, Cristiano, Priori, Roberta, Siracusano, Alessandra, Riganò, Rachele, Profumo, Elisabetta, Valesini, Guido, Sorice, Maurizio, Ortona, Elena
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526626/
https://www.ncbi.nlm.nih.gov/pubmed/16611372
http://dx.doi.org/10.1186/ar1940
_version_ 1782128927380078592
author Delunardo, Federica
Conti, Fabrizio
Margutti, Paola
Alessandri, Cristiano
Priori, Roberta
Siracusano, Alessandra
Riganò, Rachele
Profumo, Elisabetta
Valesini, Guido
Sorice, Maurizio
Ortona, Elena
author_facet Delunardo, Federica
Conti, Fabrizio
Margutti, Paola
Alessandri, Cristiano
Priori, Roberta
Siracusano, Alessandra
Riganò, Rachele
Profumo, Elisabetta
Valesini, Guido
Sorice, Maurizio
Ortona, Elena
author_sort Delunardo, Federica
collection PubMed
description Given the lack of a serological test specific for Behçet's disease, its diagnosis rests upon clinical criteria. The clinical diagnosis is nevertheless difficult because the disease manifestations vary widely, especially at the onset of disease. The aim of this study was to identify molecules specifically recognized by serum autoantibodies in patients with Behçet's disease and to evaluate their diagnostic value. We screened a cDNA library from human microvascular endothelial cells with serum IgG from two patients with Behçet's disease and isolated a reactive clone specific to the carboxy-terminal subunit of Sip1 (Sip1 C-ter). Using ELISA, we measured IgG, IgM and IgA specific to Sip1 C-ter in patients with various autoimmune diseases characterized by the presence of serum anti-endothelial cell antibodies, such as Behçet's disease, systemic lupus erythematosus, systemic sclerosis and various forms of primary vasculitis, as well as in patients with diseases that share clinical features with Behçet's disease, such as inflammatory bowel disease and uveitis. IgM immunoreactivity to Sip1 C-ter was significantly higher in patients with Behçet's disease and in patients with primary vasculitis than in the other groups of patients and healthy subjects tested (P < 10(-4 )by Mann-Whitney test). ELISA detected IgG specific to Sip1 C-ter in sera from 11/56 (20%) patients with Behçet's disease, IgM in 23/56 (41%) and IgA in 9/54 (17%). No sera from patients with systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease, uveitis or healthy subjects but 45% of sera from patients with primary vasculitis contained IgM specific to Sip1 C-ter. Serum levels of soluble E-selectin, a marker of endothelial activation and inflammation, correlated with levels of serum IgM anti Sip-1 C-ter in patients with Behçet's disease (r = 0.36, P = 0.023). In conclusion, Sip1 C-ter is a novel autoantigen in Behçet's disease. IgM specific to Sip1 C-ter might be useful in clinical practice as an immunological marker of endothelial dysfunction in vasculitis.
format Text
id pubmed-1526626
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15266262006-08-04 Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease Delunardo, Federica Conti, Fabrizio Margutti, Paola Alessandri, Cristiano Priori, Roberta Siracusano, Alessandra Riganò, Rachele Profumo, Elisabetta Valesini, Guido Sorice, Maurizio Ortona, Elena Arthritis Res Ther Research Article Given the lack of a serological test specific for Behçet's disease, its diagnosis rests upon clinical criteria. The clinical diagnosis is nevertheless difficult because the disease manifestations vary widely, especially at the onset of disease. The aim of this study was to identify molecules specifically recognized by serum autoantibodies in patients with Behçet's disease and to evaluate their diagnostic value. We screened a cDNA library from human microvascular endothelial cells with serum IgG from two patients with Behçet's disease and isolated a reactive clone specific to the carboxy-terminal subunit of Sip1 (Sip1 C-ter). Using ELISA, we measured IgG, IgM and IgA specific to Sip1 C-ter in patients with various autoimmune diseases characterized by the presence of serum anti-endothelial cell antibodies, such as Behçet's disease, systemic lupus erythematosus, systemic sclerosis and various forms of primary vasculitis, as well as in patients with diseases that share clinical features with Behçet's disease, such as inflammatory bowel disease and uveitis. IgM immunoreactivity to Sip1 C-ter was significantly higher in patients with Behçet's disease and in patients with primary vasculitis than in the other groups of patients and healthy subjects tested (P < 10(-4 )by Mann-Whitney test). ELISA detected IgG specific to Sip1 C-ter in sera from 11/56 (20%) patients with Behçet's disease, IgM in 23/56 (41%) and IgA in 9/54 (17%). No sera from patients with systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease, uveitis or healthy subjects but 45% of sera from patients with primary vasculitis contained IgM specific to Sip1 C-ter. Serum levels of soluble E-selectin, a marker of endothelial activation and inflammation, correlated with levels of serum IgM anti Sip-1 C-ter in patients with Behçet's disease (r = 0.36, P = 0.023). In conclusion, Sip1 C-ter is a novel autoantigen in Behçet's disease. IgM specific to Sip1 C-ter might be useful in clinical practice as an immunological marker of endothelial dysfunction in vasculitis. BioMed Central 2006 2006-04-12 /pmc/articles/PMC1526626/ /pubmed/16611372 http://dx.doi.org/10.1186/ar1940 Text en Copyright © 2006 Delunardo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Delunardo, Federica
Conti, Fabrizio
Margutti, Paola
Alessandri, Cristiano
Priori, Roberta
Siracusano, Alessandra
Riganò, Rachele
Profumo, Elisabetta
Valesini, Guido
Sorice, Maurizio
Ortona, Elena
Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease
title Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease
title_full Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease
title_fullStr Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease
title_full_unstemmed Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease
title_short Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease
title_sort identification and characterization of the carboxy-terminal region of sip-1, a novel autoantigen in behçet's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526626/
https://www.ncbi.nlm.nih.gov/pubmed/16611372
http://dx.doi.org/10.1186/ar1940
work_keys_str_mv AT delunardofederica identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT contifabrizio identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT marguttipaola identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT alessandricristiano identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT prioriroberta identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT siracusanoalessandra identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT riganorachele identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT profumoelisabetta identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT valesiniguido identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT soricemaurizio identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease
AT ortonaelena identificationandcharacterizationofthecarboxyterminalregionofsip1anovelautoantigeninbehcetsdisease